top of page

Dr.Panomwat Amornphimoltham, D.D.S., PhD

 Director of Research Center

Phone: 66-02-299-0935



  • PhD. (Oral Pathology) 

2007 University of Maryland, Baltimore, USA

  • D.D.S. 

1995 Prince of Songkla University, THAILAND

Employment & Experiences

  • Acting Director of Research Center

2017-present International College of Dentistry, Walailak University, THAILAND

  • Project Scientist

2016 Gutkind lab, Moores Cancer Center, University of California San Diego, USA​

  • Staff Scientist

2010 Intracellular Membrane Trafficking Unit, Oral and Pharyngeal Cancer Branch, NIDCR, NIH, USA​​

  • Research Fellow

2008 Intracellular Membrane Trafficking Unit, Oral and Pharyngeal Cancer Branch, NIDCR, NIH, USA​

  • Post Doctoral Fellow

2000 Molecular Carcinogenesis Unit, Oral and Pharyngeal Cancer Branch, NIDCR, NIH, USA​

  • Faculty

1996 Department of Oral Biology and Occlusion, Faculty of Dentistry, Prince of Songkla University, THAILAND

Honors & Awards

2007    NIH Performance Award, National Institute of Dental Research, NIH, USA

2012    Outstanding abstract for short talk at Membrane Dynamics in Cancer             Conference;    Beatson international cancer research, UK

Research Interests

1. Head and Neck Cancer Signaling Pathway

2. Cancer Animal models 

3. Intravital Imaging

4. Oral Mucositis

5. Epithelial Biology

Latest Publications

  1. Fukusumi T, Guo TW, Sakai A, Ando M, Ren S, Haft S, Liu C, Amornphimoltham P, Gutkind JS, Califano JA.The NOTCH4-HEY1 Pathway Induces Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2018 Feb 1;24(3):619-633.​​

  2. Zhao X, Deng P, Iglesias-Bartolome R, Amornphimoltham P, Steffen DJ, Jin Y, Molinolo AA, de Castro LF, Ovejero D, Yuan Q, Chen Q, Han X, Bai D, Taylor SS, Yang Y, Collins MT, Gutkind JS.Expression of an active Gαs mutant in skeletal stem cells is sufficient and necessary for fibrous dysplasia initiation and maintenance.Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):E428-E437.

  3. Amornphimoltham P, Thompson J, Melis N, Weigert R. Non-invasive intravital imaging of head and neck squamous cell carcinomas in live mice. Methods. 2017 Sep 1;128:3-11.

  4. Amornphimoltham P, Roth SJ, Idekar T and Gutkind JS. Targeting the mTOR Signaling Circuitry in Head and Neck Cancer, (2017) In Squamous cell Carcinoma: Molecular Therapeutic Targets, Warnakulasuriya S and ,Khan Z (Ed.) (Springer) ISBN: 978-94-024-1083-9; p 163-182

  5. Callejas-Valera JL, Iglesias-Bartolome R, Amornphimoltham P, Palacios-Garcia J, Martin D, Califano JA, Molinolo AA, Gutkind JS. mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model. Carcinogenesis. 2016 Oct;37(10):1014-25. 

bottom of page